Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant
Medicare pricing data for 90 providers across 11 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS code 81305) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $171.83, but hospitals typically charge $228.51 — a 1.3x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $171.83, your out-of-pocket cost would be approximately $34.37. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.3x more than what Medicare allows for this procedure. Medicare actually pays $171.83 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Pennsylvania | $172 | $175 | 2 | 18 | +0.0% |
| Tennessee | $172 | $424 | 2 | 130 | +0.0% |
| Utah | $172 | $353 | 2 | 43 | +0.0% |
| Washington | $172 | $415 | 6 | 128 | +0.0% |
| Arizona | $172 | $438 | 2 | 323 | +0.0% |
| Florida | $172 | $200 | 24 | 13,154 | +0.0% |
| California | $172 | $396 | 5 | 867 | -0.0% |
| New Jersey | $171 | $590 | 7 | 92 | -0.6% |
| Connecticut | $170 | $611 | 2 | 69 | -1.2% |
| Texas | $170 | $414 | 10 | 37 | -1.2% |
| Minnesota | $168 | $669 | 2 | 47 | -2.0% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber